Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1ELX - US5184391044 - Common Stock

92.2 EUR
+4.2 (+4.77%)
Last: 1/5/2026, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, 1ELX scores 3 out of 10 in our fundamental rating. 1ELX was compared to 13 industry peers in the Personal Care Products industry. 1ELX has a bad profitability rating. Also its financial health evaluation is rather negative. 1ELX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ELX was profitable.
1ELX had a positive operating cash flow in the past year.
1ELX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years 1ELX had a positive operating cash flow.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

The Return On Assets of 1ELX (-4.81%) is worse than 86.67% of its industry peers.
Looking at the Return On Equity, with a value of -23.91%, 1ELX is doing worse than 86.67% of the companies in the same industry.
The Return On Invested Capital of 1ELX (4.69%) is worse than 73.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ELX is significantly below the industry average of 12.34%.
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROIC 4.69%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

The Operating Margin of 1ELX (8.72%) is worse than 60.00% of its industry peers.
In the last couple of years the Operating Margin of 1ELX has declined.
1ELX has a better Gross Margin (74.18%) than 93.33% of its industry peers.
1ELX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 74.18%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

1ELX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
1ELX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1ELX has a worse debt to assets ratio.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.36. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.36, 1ELX is in line with its industry, outperforming 53.33% of the companies in the same industry.
1ELX has a debt to FCF ratio of 7.01. This is a slightly negative value and a sign of low solvency as 1ELX would need 7.01 years to pay back of all of its debts.
The Debt to FCF ratio of 1ELX (7.01) is worse than 60.00% of its industry peers.
1ELX has a Debt/Equity ratio of 1.88. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.88, 1ELX is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Altman-Z 3.36
ROIC/WACC0.62
WACC7.59%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.32. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1ELX (1.32) is better than 66.67% of its industry peers.
1ELX has a Quick Ratio of 1.32. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.92, 1ELX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

The earnings per share for 1ELX have decreased strongly by -36.12% in the last year.
The earnings per share for 1ELX have been decreasing by -18.22% on average. This is quite bad
The Revenue has decreased by -6.53% in the past year.
The Revenue has been growing slightly by 0.04% on average over the past years.
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%

3.2 Future

The Earnings Per Share is expected to grow by 28.75% on average over the next years. This is a very strong growth
1ELX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y47.45%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
EPS Next 5Y28.75%
Revenue Next Year4.25%
Revenue Next 2Y4.16%
Revenue Next 3Y4.41%
Revenue Next 5Y3.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 64.48, the valuation of 1ELX can be described as expensive.
1ELX's Price/Earnings ratio is a bit more expensive when compared to the industry. 1ELX is more expensive than 73.33% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.00. 1ELX is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 35.35, the valuation of 1ELX can be described as expensive.
1ELX's Price/Forward Earnings ratio is rather expensive when compared to the industry. 1ELX is more expensive than 80.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.70. 1ELX is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 64.48
Fwd PE 35.35
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued more expensive than 86.67% of the companies in the same industry.
1ELX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1ELX is more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.24
EV/EBITDA 20.46
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

1ELX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1ELX's earnings are expected to grow with 36.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)N/A
EPS Next 2Y42.7%
EPS Next 3Y36.61%

2

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.30%. Purely for dividend investing, there may be better candidates out there.
1ELX's Dividend Yield is slightly below the industry average, which is at 1.98.
1ELX's Dividend Yield is slightly below the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of 1ELX has a limited annual growth rate of 4.31%.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1ELX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
1ELX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-54.3%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (1/5/2026, 7:00:00 PM)

92.2

+4.2 (+4.77%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners91.7%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap33.23B
Revenue(TTM)14.44B
Net Income(TTM)-930.00M
Analysts71.11
Price Target86.68 (-5.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend1.47
Dividend Growth(5Y)4.31%
DP-54.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.2%
Min EPS beat(2)0.44%
Max EPS beat(2)75.96%
EPS beat(4)4
Avg EPS beat(4)65.82%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)73.78%
EPS beat(12)11
Avg EPS beat(12)86.84%
EPS beat(16)15
Avg EPS beat(16)68.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)1
Avg Revenue beat(12)-1.68%
Revenue beat(16)2
Avg Revenue beat(16)-1.82%
PT rev (1m)6.95%
PT rev (3m)19.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.13%
EPS NY rev (1m)0.49%
EPS NY rev (3m)-0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 64.48
Fwd PE 35.35
P/S 2.69
P/FCF 37.24
P/OCF 24.29
P/B 10
P/tB N/A
EV/EBITDA 20.46
EPS(TTM)1.43
EY1.55%
EPS(NY)2.61
Fwd EY2.83%
FCF(TTM)2.48
FCFY2.69%
OCF(TTM)3.8
OCFY4.12%
SpS34.22
BVpS9.22
TBVpS-4.58
PEG (NY)1.36
PEG (5Y)N/A
Graham Number17.22
Profitability
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROCE 8.84%
ROIC 4.69%
ROICexc 5.55%
ROICexgc 10.76%
OM 8.72%
PM (TTM) N/A
GM 74.18%
FCFM 7.24%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexgc growth 3Y-33.25%
ROICexgc growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Debt/EBITDA 3.52
Cap/Depr 67.84%
Cap/Sales 3.86%
Interest Coverage 3.58
Cash Conversion 76.98%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.92
Altman-Z 3.36
F-Score5
WACC7.59%
ROIC/WACC0.62
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
EPS Next Y47.45%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
EPS Next 5Y28.75%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%
Revenue Next Year4.25%
Revenue Next 2Y4.16%
Revenue Next 3Y4.41%
Revenue Next 5Y3.86%
EBIT growth 1Y-21.3%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year106.84%
EBIT Next 3Y38.64%
EBIT Next 5Y27.48%
FCF growth 1Y171.62%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-18.8%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%

ESTEE LAUDER COMPANIES-CL A / 1ELX.MI FAQ

What is the ChartMill fundamental rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI.


What is the valuation status for 1ELX stock?

ChartMill assigns a valuation rating of 1 / 10 to ESTEE LAUDER COMPANIES-CL A (1ELX.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTEE LAUDER COMPANIES-CL A?

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a profitability rating of 3 / 10.


What is the valuation of ESTEE LAUDER COMPANIES-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 64.48 and the Price/Book (PB) ratio is 10.


How sustainable is the dividend of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

The dividend rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 2 / 10 and the dividend payout ratio is -54.3%.